Incorporating Redo-TAVR Feasibility Into Lifelong Aortic Valve Management

Circ Cardiovasc Interv. 2023 Nov;16(11):e013571. doi: 10.1161/CIRCINTERVENTIONS.123.013571. Epub 2023 Nov 21.

Authors

R Michael Reul¹, Alexander P Nissen¹, Stephanie K Tom², Elizabeth L Norton¹, Kendra J Grubb¹

Affiliations

¹ Division of Cardiothoracic Surgery, Department of Surgery (R.M.R., A.P.N., E.L.N., K.J.G.), Emory University School of Medicine, Atlanta, GA.
² Department of Surgery (S.K.T.), Emory University School of Medicine, Atlanta, GA.

PMID: 37988435
DOI: 10.1161/CIRCINTERVENTIONS.123.013571

No abstract available

Keywords: Editorials; expansion; reoperation; surgical aortic valve replacement; transcatheter aortic valve replacement.

Publication types

Editorial
Comment

MeSH terms

Aortic Valve / diagnostic imaging
Aortic Valve / surgery
Aortic Valve Stenosis* / diagnostic imaging
Aortic Valve Stenosis* / surgery
Feasibility Studies
Heart Valve Prosthesis Implantation* / adverse effects
Heart Valve Prosthesis*
Humans
Reoperation
Risk Factors
Transcatheter Aortic Valve Replacement* / adverse effects
Treatment Outcome